It looks like Y-90 has found other application uses, which ADMD should be able to leverage.
SIR: Y-90 radioembolization may offer chemo alternative Article Thumbnail ImageMarch 25, 2014 -- Radioembolization with yttrium-90 (Y-90) shows promise in treating breast cancer patients whose disease has spread to the liver and who have exhausted all other treatment options, according to a study presented at the Society of Interventional Radiology (SIR) annual meeting.
Market Data 
Markets 
AI
